Clinical Trial Update: A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

View source ↗

Summary

Astellas Korea is recruiting adults in South Korea for a survey study of cancer patients who receive PADCEV injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Padcev (enfortumab vedotin)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Urothelial Cancer | Status: RECRUITING